Isabel S Naarmann-De Vries, Tim Preissendörfer, Julian König, Christoph Dieterich
{"title":"<i>Ava</i>II senses m<sup>6</sup>A and inosine sites and enables targeted nanopore direct RNA-sequencing.","authors":"Isabel S Naarmann-De Vries, Tim Preissendörfer, Julian König, Christoph Dieterich","doi":"10.3389/fmolb.2025.1593637","DOIUrl":null,"url":null,"abstract":"<p><p>Nanopore direct RNA-sequencing is the first commercialized method to sequence native RNA directly, thus preserving RNA modifications. With the current technology, sequencing is initiated from the 3'end. While for relatively short polyadenylated RNAs, full coverage is obtained, the 5'end of many long RNAs is not sufficiently covered resulting in a substantial 3'bias. We aimed to cleave such RNAs in a sequence-specific manner in order to generate new unique 3'ends that can be targeted by custom adapters. We identified the DNA endonuclease <i>Ava</i>II as a candidate enzyme. <i>Ava</i>II was originally described to cleave double-stranded DNA at GGWCC sites, where W is an A or T. Here, we show that <i>Ava</i>II cleaves also long RNAs in GGACC contexts, if hybridized to a complementary DNA oligo. Furthermore, we provide evidence that <i>Ava</i>II cleavage of RNA is modification sensitive and does not cleave RNA with m<sup>6</sup>A or inosine in the central position. We propose <i>Ava</i>II as \"methylation sensor\" for the <i>bona fide</i> DRACH recognition motif GGACC of the m<sup>6</sup>A writer complex. Finally, we show that <i>Ava</i>II cleavage products are accessible to targeted Nanopore direct RNA-sequencing.</p>","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"12 ","pages":"1593637"},"PeriodicalIF":3.9000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12336230/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Molecular Biosciences","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3389/fmolb.2025.1593637","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Nanopore direct RNA-sequencing is the first commercialized method to sequence native RNA directly, thus preserving RNA modifications. With the current technology, sequencing is initiated from the 3'end. While for relatively short polyadenylated RNAs, full coverage is obtained, the 5'end of many long RNAs is not sufficiently covered resulting in a substantial 3'bias. We aimed to cleave such RNAs in a sequence-specific manner in order to generate new unique 3'ends that can be targeted by custom adapters. We identified the DNA endonuclease AvaII as a candidate enzyme. AvaII was originally described to cleave double-stranded DNA at GGWCC sites, where W is an A or T. Here, we show that AvaII cleaves also long RNAs in GGACC contexts, if hybridized to a complementary DNA oligo. Furthermore, we provide evidence that AvaII cleavage of RNA is modification sensitive and does not cleave RNA with m6A or inosine in the central position. We propose AvaII as "methylation sensor" for the bona fide DRACH recognition motif GGACC of the m6A writer complex. Finally, we show that AvaII cleavage products are accessible to targeted Nanopore direct RNA-sequencing.
期刊介绍:
Much of contemporary investigation in the life sciences is devoted to the molecular-scale understanding of the relationships between genes and the environment — in particular, dynamic alterations in the levels, modifications, and interactions of cellular effectors, including proteins. Frontiers in Molecular Biosciences offers an international publication platform for basic as well as applied research; we encourage contributions spanning both established and emerging areas of biology. To this end, the journal draws from empirical disciplines such as structural biology, enzymology, biochemistry, and biophysics, capitalizing as well on the technological advancements that have enabled metabolomics and proteomics measurements in massively parallel throughput, and the development of robust and innovative computational biology strategies. We also recognize influences from medicine and technology, welcoming studies in molecular genetics, molecular diagnostics and therapeutics, and nanotechnology.
Our ultimate objective is the comprehensive illustration of the molecular mechanisms regulating proteins, nucleic acids, carbohydrates, lipids, and small metabolites in organisms across all branches of life.
In addition to interesting new findings, techniques, and applications, Frontiers in Molecular Biosciences will consider new testable hypotheses to inspire different perspectives and stimulate scientific dialogue. The integration of in silico, in vitro, and in vivo approaches will benefit endeavors across all domains of the life sciences.